1-231040166-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_198552.3(FAM89A):āc.46G>Cā(p.Val16Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000212 in 1,196,312 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_198552.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAM89A | NM_198552.3 | c.46G>C | p.Val16Leu | missense_variant | 1/2 | ENST00000366654.5 | NP_940954.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAM89A | ENST00000366654.5 | c.46G>C | p.Val16Leu | missense_variant | 1/2 | 1 | NM_198552.3 | ENSP00000355614.4 |
Frequencies
GnomAD3 genomes AF: 0.000182 AC: 27AN: 147974Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000919 AC: 1AN: 10878Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 7226
GnomAD4 exome AF: 0.000217 AC: 227AN: 1048230Hom.: 0 Cov.: 31 AF XY: 0.000214 AC XY: 107AN XY: 499936
GnomAD4 genome AF: 0.000182 AC: 27AN: 148082Hom.: 0 Cov.: 31 AF XY: 0.000180 AC XY: 13AN XY: 72246
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 07, 2024 | The c.46G>C (p.V16L) alteration is located in exon 1 (coding exon 1) of the FAM89A gene. This alteration results from a G to C substitution at nucleotide position 46, causing the valine (V) at amino acid position 16 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at